Researchers at Tezpur University in India have identified a panel of circulating microRNAs in blood serum that may help distinguish gallbladder cancer from benign conditions, offering a potential ...

A newly published study highlights how a quick and simple blood test may help physicians provide a more accurate diagnosis of Alzheimer's disease. Led by Jordi ...

Also known as metastatic breast cancer (mBC), Stage IV means the disease has spread to other parts of the body, and approximately 1 in 3 people with breast cancer develop mBC.³ In Lynn’s case, her ...

A new screening tool can identify the hidden driver of a silent killer through standard blood work, bypassing the need to ask ...

Shifting the focus from organ to biomarker has unlocked new options for rare and advanced cancers. Uneven efficacy, diagnostic access, and regulation still slow clinical rollout.

Survey findings highlight need for improved education and access to precision medicine in the Japanese American ...

Experts share what patients should know from the 2026 ASCO GU Cancer Symposium, highlighting biomarkers, trial options and personalized care decisions. As the 2026 ASCO Genitourinary (GU) Cancers ...

In the quest for RNA biomarkers indicative of fruit maturity, a cost-effective, reliable workflow is crucial. Accurate harvest timing is critical for shelf life and apple quality, but at present, ...

A new light-based sensor detects cancer markers at near-zero concentrations.

Tiziana Life Sciences Ltd (NASDAQ:TLSA) said new biomarker data from an expanded-access program showed its experimental ...

Plasma p-tau217 levels predict the timing of Alzheimer’s onset in cognitively unimpaired adults in the research that could potentially guide research and preventive trials.

IRSF investment positions organization at the forefront of early-stage Rett research as genomic medicine reshapes rare ...